Patent · US Active

Indoleamine 2,3-dioxygenase inhibitors and use of same in medicine

US11111230B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

ADLAI NORTYE BIOPHARMA CO., LTD. · CN

Inventors

Pan Li · Lexington, US
Qiaodong WEN · Hangzhou City, CN
Ji Wang · Amherst, US
Quan Gan · Wuxi, CN
Yang Lu · Hefei, CN
Donghui Yang · 安丰镇, CN

Key dates

Filing date	Jun 26, 2020
Grant date	Sep 7, 2021
Priority date	—
Expiry date	Jun 26, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound represented by formula I, a pharmaceutical composition containing the compound of formula I, a method for inhibiting indoleamine 2,3-dioxygenase, and its use in medicine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.